Publications

Below you can find access to relevant publications for further information

 

GOLD 2017 Strategy Report

 

http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/

 

Lung function decline in COPD

Tantucci C, Modina D. Int J Chron Obstruct Pulmon Dis 2012; 7: 95–99.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282601/

 

Decline of physical activity with COPD

Watz H, et al. Eur Respir J 2009; 33: 262−272.

https://www.ncbi.nlm.nih.gov/pubmed/19010994

 

Comparison of LAMA/LABA vs LABA/ICS

Beeh K-M, et al. Int J Chron Obstruct Pulm Dis 2016;11:193-205.

https://www.ncbi.nlm.nih.gov/pubmed/26893551

 

Wedzicha JA, et al. New Engl J Med 2016;374:2222-34.

https://www.ncbi.nlm.nih.gov/pubmed/27181606

 

Horita N, et al. Cochrane Database Syst Rev 2017;2:CD012066.

http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD012066.pub2/abstract

 

SPIOLTO® RESPIMAT® vs. monotherapy in COPD

Buhl R, et al. Eur Respir J 2015; 45:969-79.

https://www.ncbi.nlm.nih.gov/pubmed/25573406

 

Ferguson GT, et al. Adv Ther. 2015; 32:523-536 and supplementary information.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486785/

 

Singh D, et al. Respir Res. 2016;17:73.

https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-016-0387-7